• Français

Centre de recherche
Wednesday, July 21 2021
Press release

Youth and COVID-19

The CHU Sainte-Justine continues its fight against the coronavirus

MONTREAL, July 21, 2021 – Because of their expertise, clinician-researchers Hélène Decaluwe, Elie Haddad and Fabien Touzot and their colleagues from the Immunology-Rheumatology Department at CHU Sainte-Justine will be participating in the national VISID project led at the Ottawa Hospital and at the University of Ottawa in terms of pediatrics, to understand how well do COVID-19 vaccines work in people with inherited and medication-related immune deficiencies.

People with inherited primary immune deficiencies have a greater risk of developing severe COVID-19. People with multiple sclerosis, arthritis and other immune-mediated diseases may also be at risk because medications for these conditions often suppress the immune system.

“Fortunately, children with primary immune deficiencies seem less affected by severe forms of COVID-19 than adults. However, they may be less able to acquire good protection after vaccination against the virus,” indicates Dr. Hélène Decaluwe, clinician-researcher in pediatric immunology at CHU Sainte-Justine and associate professor in the Department of Pediatrics at the University of Montreal.

Under the direction of Dr. Juthaporn Cowan, infectious disease physician and associate scientist at the Ottawa Hospital and assistant professor at the University of Ottawa, the research team aims to recruit 460 participants with inherited or medication-related immune deficiencies from twelve sites across Canada (in Ottawa, Montreal, Toronto, Halifax, Winnipeg, Edmonton, Calgary and Vancouver). The researchers also hope to recruit healthy individuals over 12 who have not yet been vaccinated, but plan to be, as a control group.

The researchers will collect blood samples from the participants to study the body’s response to COVID-19 vaccines, including antibody levels and T cell response. Participants will also fill out questionnaires and be followed by health care professionals to assess any vaccine side effects.

“Our study will provide crucial data to help us protect people with immune deficiencies against COVID-19,” said Dr. Cowan. “It will also help us learn more about which compartment of the immune system is essential in the COVID-19 vaccine response, so that better vaccines can be developed in the future.”

"CHU Sainte-Justine's contribution to clinical and basic research in the field of pediatric immune diseases is a major on an international scale. By participating in this study, it will be possible for us to understand the impact of vaccination specific in this population and thus help to push our expertise even further in the care and monitoring of young patients with primary immune deficiencies,” explains Dr. Decaluwe.

Dr. Decaluwe is also a co-principal investigator for the PSI Foundation-funded PITCH Project which aims to understand protective immunity against COVID-19 in children.

Antibodies develop after an acute infection with SARS-CoV-2, but antibody levels can decline rapidly in some individuals, especially if the infection is mild or asymptomatic. New data suggests that long-term immunity may also be provided by T cells, which are essential for controlling and eradicating viral infections as well as immune memory.

There is currently very little data on the immune response of T cells in children infected with COVID-19. In the present study, the research team will measure the response of T cells 2, 6 and 12 months after confirmed infection with COVID-19.

The participants are also part of another joint study (the PATCH study) examining the antibody response to COVID-19 and the research team wants to compare the response of T cells and antibodies at similar time points over a period of one year. The data obtained will be able to inform public health policies and optimal COVID-19 vaccine coverage targets for adults and children.

“You should know that it is the duration of immunity to SARS-CoV-2 that will determine the course of this pandemic,” concludes Dr. Decaluwe.

– 30 –

À propos du Centre de recherche du CHU Sainte-Justine

Le Centre de recherche du CHU Sainte-Justine est un établissement phare en recherche mère-enfant affilié à l’Université de Montréal. Axé sur la découverte de moyens de prévention innovants, de traitements moins intrusifs et plus rapides et d’avenues prometteuses de médecine personnalisée, il réunit plus de 210 chercheurs, dont plus de 110 chercheurs cliniciens, ainsi que 450 étudiants de cycles supérieurs et postdoctorants. Le centre est partie intégrante du Centre hospitalier universitaire Sainte-Justine, le plus grand centre mère-enfant au Canada et le deuxième centre pédiatrique en importance en Amérique du Nord. 

CHU Sainte-Justine

Maude Hoffmann
Communications, Centre de recherche du CHU Sainte-Justine

Personne-ressource auprès des médias :

Florence Meney
Conseillère-cadre – médias externes
CHU Sainte-Justine
Tél. : 514-755-2516

Persons mentioned in the text
About this page
Updated on 9/28/2022
Created on 5/17/2022
Alert or send a suggestion

Grow Beyond our wildest dreams

With the support of donors like you, at the heart of the Grow Beyond campaign, we are leading healthcare teams towards the opportunities offered by science and new technologies, so that every child, no matter where in Quebec, has access to the unique expertise and know-how of CHU Sainte-Justine. Together, let's join forces for their future.

Grow Beyond with us.

Contact Us

514 345-4931


© 2006-2014 CHU Sainte-Justine.
All rights reserved.
Terms of Use, Confidentiality, Security


Les informations contenues dans le site « CHU Sainte-Justine » ne doivent pas être utilisées comme un substitut aux conseils d’un médecin dûment qualifié et autorisé ou d’un autre professionnel de la santé. Les informations fournies ici le sont à des fins exclusivement éducatives et informatives.

Consultez votre médecin si vous croyez être malade ou composez le 911 pour toute urgence médicale.

CHU Sainte-Justine